Risk of Chronic Kidney Disease and Implications in Patients with Atrial Fibrillation for the Development of Major Adverse Cardiovascular Events with Machine Learning
Medical Sciences · 2025
DOI: 10.3390/medsci13040289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Pedro Moltó-Balado und 8 weiteren Autor:innen. Beteiligte Einrichtung: CSI Llíria, Departament de Salut de Arnau de Vilanova, Conselleria de Sanitat, 46160 Valencia, Spain. Hauptthemen laut MEDLINE: Atrial Fibrillation, Renal Insufficiency, Chronic, Machine Learning, Cardiovascular Diseases. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) and chronic kidney disease (CKD) often overlap and may amplify cardiovascular risk. Whether renal dysfunction should be incorporated into composite cardiovascular endpoints in AF remains uncertain. We aimed to quantify AF-associated risk of MACE and evaluate the incremental prognostic value of kidney measures (eGFR and albuminuria) to inform composite outcomes and clinical management.
Methods
We performed a retrospective, community-based cohort study of 40,297 adults aged 65–95 years. Individuals with incident AF (n = 2574) were followed for 5 years. MACE and components were ascertained from linked health records; only events after AF diagnosis were analyzed. Cox models estimated adjusted hazard ratios (HRs). Risk was further stratified by eGFR stages and urine albumin-to-creatinine ratio (UACR) categories. Exploratory machine learning (ML) was developed to predict MACE in patients with AF and CKD, with model interpretability assessed by feature importance analysis.
Results
Incident AF was associated with higher risk of MACE (HR 3.52), CKD (HR 1.97) and all-cause mortality (HR 1.14). CKD was nearly twice more frequent in AF than in non-AF (30.9% vs. 14.5%; p < 0.001). Among patients with AF, a graded eGFR–risk relationship was observed: compared with higher eGFR, MACE risk increased across G3a–G5, peaking in G5 (HR 2.08). Albuminuria showed a parallel gradient: versus UACR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CSI Llíria, Departament de Salut de Arnau de Vilanova, Conselleria de Sanitat, 46160 Valencia, Spain.
- Clínica Equilibria, 46160 Valencia, Spain.
- Ebrictus Research Group, Research Support Unit Terres de l'Ebre, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 43500 Tortosa, Spain.
- Primary Health-Care Center Tortosa Est, Institut Català de la Salut, Primary Care Service (SAP) Terres de l'Ebre, 43500 Tortosa, Spain.
- Nephrology Department at Dénia Hospital, Conselleria de Sanitat, 03700 Alicante, Spain.
- Institut d'Educació Secundària El Caminàs, Conselleria d'Educació, 12003 Castellón, Spain.
ORCID-Profile: Pedro Moltó-Balado, Josep-Lluís Clua-Espuny, Andrea Simeó-Monzó, Jorge Canela-Royo, Alba Del Barrio-González
Zitieren
APA
Moltó-Balado, P., Clua-Espuny, J. L., Tarongi-Vidal, C., Barrios-Carmona, P., Alonso-Barberán, V., Balado-Albiol, M. T., Simeó-Monzó, A., Canela-Royo, J., & Del Barrio-González, A. (2025). Risk of Chronic Kidney Disease and Implications in Patients with Atrial Fibrillation for the Development of Major Adverse Cardiovascular Events with Machine Learning. Medical Sciences. https://doi.org/10.3390/medsci13040289
Vancouver
Moltó-Balado P, Clua-Espuny JL, Tarongi-Vidal C, Barrios-Carmona P, Alonso-Barberán V, Balado-Albiol MT, et al. Risk of Chronic Kidney Disease and Implications in Patients with Atrial Fibrillation for the Development of Major Adverse Cardiovascular Events with Machine Learning. Medical Sciences. 2025. doi:10.3390/medsci13040289
BibTeX
@article{MoltBalado2025,
author = {Moltó-Balado, Pedro and Clua-Espuny, Josep-Lluís and Tarongi-Vidal, Carlos and Barrios-Carmona, Paula and Alonso-Barberán, Victor and Balado-Albiol, Maria-Teresa and Simeó-Monzó, Andrea and Canela-Royo, Jorge and Del Barrio-González, Alba},
title = {Risk of Chronic Kidney Disease and Implications in Patients with Atrial Fibrillation for the Development of Major Adverse Cardiovascular Events with Machine Learning},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13040289}
}
EUVIMED